Preparation for detection, diagnosis or prognostic evaluation of esophageal cancer, medicament for treating esophageal cancer and application of RND2 gene
A technology of esophageal cancer and genes, which is applied in the field of tumor molecular biology, can solve the problems of no preparations for evaluating the prognosis of esophageal cancer, and achieve the effect of early diagnosis and timely gene diagnosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0081] The drug for treating esophageal cancer in this embodiment includes an agent that promotes the expression of RND2 gene.
[0082] The reagent may be: a reagent containing the RND2 gene, a reagent formed from a vector carrying the RND2 gene, a reagent formed from a host cell carrying the RND2 gene, or a reagent containing the RND2 protein.
Embodiment 2
[0084] The drug for treating esophageal cancer in this embodiment includes an agent that promotes the stability of the RND2 gene expression product. Specifically, it is an RND2 protein stabilizer.
Embodiment 3
[0086] The drug for treating esophageal cancer in this embodiment includes an agent that increases the activity of the RND2 gene expression product.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com